JMUEX
Price
$27.25
Change
-$0.05 (-0.18%)
Updated
Nov 13 closing price
VTSMX
Price
$144.10
Change
-$0.10 (-0.07%)
Updated
Nov 13 closing price
Ad is loading...

JMUEX vs VTSMX

Header iconJMUEX vs VTSMX Comparison
Open Charts JMUEX vs VTSMXBanner chart's image
JPMorgan US Equity L
Price$27.25
Change-$0.05 (-0.18%)
VolumeN/A
CapitalizationN/A
Vanguard Total Stock Mkt Idx I
Price$144.10
Change-$0.10 (-0.07%)
VolumeN/A
CapitalizationN/A
JMUEX vs VTSMX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JMUEX vs. VTSMX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JMUEX is a StrongBuy and VTSMX is a Buy.

FUNDAMENTALS
Fundamentals
VTSMX has more cash in the bank: 1.73T vs. JMUEX (33.3B). VTSMX pays higher dividends than JMUEX: VTSMX (1.26) vs JMUEX (0.79). JMUEX was incepted earlier than VTSMX: JMUEX (31 years) vs VTSMX (33 years). JMUEX is a more actively managed with annual turnover of: 47.00 vs. VTSMX (2.00). VTSMX has a lower initial minimum investment than JMUEX: VTSMX (3000) vs JMUEX (3000000). JMUEX (38.17) and VTSMX (36.46) have marching annual gain over last year. VTSMX return over 5 years is better than : 89.01 vs. JMUEX (68.53).
JMUEXVTSMXJMUEX / VTSMX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence31 years33 years-
Gain YTD28.73124.948115%
Front LoadN/AN/A-
Min. Initial Investment30000003000100,000%
Min. Initial Investment IRAN/AN/A-
Net Assets33.3B1.73T2%
Annual Yield % from dividends0.791.2663%
Returns for 1 year38.1736.46105%
Returns for 3 years15.5222.8968%
Returns for 5 years68.5389.0177%
Returns for 10 years87.73193.5945%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MLI93.45-1.89
-1.98%
Mueller Industries
CEIX126.80-2.94
-2.27%
CONSOL Energy
CSTL32.78-1.00
-2.96%
Castle Biosciences
SKYX1.26-0.06
-4.55%
SKYX Platforms Corp
RSLS5.36-0.30
-5.30%
ReShape Lifesciences Inc